- Home
- BEAT vs NDP Comparison
BEAT vs NDP Comparison
Compare BEAT & NDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAT
- NDP
- Stock Information
- Founded
- BEAT 2015
- NDP 2005
- Country
- BEAT United States
- NDP United States
- Employees
- BEAT N/A
- NDP N/A
- Industry
- BEAT Retail: Computer Software & Peripheral Equipment
- NDP Finance/Investors Services
- Sector
- BEAT Technology
- NDP Finance
- Exchange
- BEAT Nasdaq
- NDP Nasdaq
- Market Cap
- BEAT 62.7M
- NDP 71.4M
- IPO Year
- BEAT 2021
- NDP N/A
- Fundamental
- Price
- BEAT $2.29
- NDP $43.09
- Analyst Decision
- BEAT Buy
- NDP
- Analyst Count
- BEAT 1
- NDP 0
- Target Price
- BEAT $8.00
- NDP N/A
- AVG Volume (30 Days)
- BEAT 96.6K
- NDP 6.1K
- Earning Date
- BEAT 11-07-2024
- NDP 01-01-0001
- Dividend Yield
- BEAT N/A
- NDP 7.54%
- EPS Growth
- BEAT N/A
- NDP N/A
- EPS
- BEAT N/A
- NDP N/A
- Revenue
- BEAT N/A
- NDP N/A
- Revenue This Year
- BEAT N/A
- NDP N/A
- Revenue Next Year
- BEAT N/A
- NDP N/A
- P/E Ratio
- BEAT N/A
- NDP N/A
- Revenue Growth
- BEAT N/A
- NDP N/A
- 52 Week Low
- BEAT $1.06
- NDP $26.46
- 52 Week High
- BEAT $3.39
- NDP $33.43
- Technical
- Relative Strength Index (RSI)
- BEAT 47.26
- NDP 76.93
- Support Level
- BEAT $2.33
- NDP $42.54
- Resistance Level
- BEAT $2.61
- NDP $43.02
- Average True Range (ATR)
- BEAT 0.19
- NDP 0.40
- MACD
- BEAT -0.03
- NDP 0.28
- Stochastic Oscillator
- BEAT 13.73
- NDP 99.55
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About NDP Tortoise Energy Independence Fund Inc.
Tortoise Energy Independence Fund, Inc. is a non-diversified closed-end management investment company. Its primary investment objective to seek a high level of total return with an emphasis on current distributions. The fund invests primarily in equity securities of upstream North American energy companies that engage in the exploration and production of crude oil, condensate, natural gas and natural gas liquids that generally have a presence in North American oil and gas fields, including shale reservoirs.